Project Toxicologist - Respiratory Safety

AstraZeneca AB / Biomedicinjobb / Göteborg
2019-10-03
Observera att sista ansökningsdag har passerat.
➡️ Klicka här för den senare publicerade platsannonsen "Project Toxicologist - Respiratory Safety" (publicerad 2019-11-11) ⬅️


Visa alla biomedicinjobb i Göteborg, Mölndal, Partille, Kungälv, Lerum eller i hela Sverige
Visa alla jobb hos AstraZeneca AB i Göteborg, Mölndal, Södertälje, Solna, Stockholm eller i hela Sverige

Are you a Toxicologist excited by an opportunity to be a key player in the discovery of safe innovative medicines? Would you like to apply your expertise in a company that is accelerating innovative science and turns ideas into life changing medicines? Join us to be part of the development of future treatments of respiratory diseases!

We are now recruiting a Project Toxicologist / Toxicology Project Leader to join the Respiratory, Inflammation and Autoimmunity (RIA) Safety function at AstraZeneca's dynamic R&D site in Gothenburg, Sweden. For the right candidate, placement in Cambridge, UK is also an option.

Working at AstraZeneca means being entrepreneurial, thinking big and working together to make the impossible a reality. This role will give you the opportunity to work at the forefront of toxicology and safety science within respiratory diseases, one of AstraZeneca's main therapy areas. In a multidisciplinary environment you will play a key role in progressing a rich and diverse pipeline of both small and large molecules.

As a Project Toxicologist / Toxicology Project Leader, you will combine your experience in toxicology and drug development with strong communication and interpersonal skills to communicate across levels of internal and external stakeholders. In this role, you will be key for the progression of drug candidates to deliver novel medicines to patients within respiratory disease.

Our Function

RIA Safety is a leading respiratory safety organization that develops and integrates innovative safety science with toxicology excellence to drive the design, selection and successful development of novel treatments for patients with respiratory disease. We are a diverse international department that comprises project toxicologists, discovery safety specialists, respiratory safety experts and experimental scientists. As part of Clinical Pharmacology & Safety Sciences (CPSS), which contains all non-clinical safety functions that support the entire AstraZeneca Portfolio, we have a strong focus on talent development. You will be able to develop your skills, competences and scientific leadership by working together with leaders in investigative toxicology, regulatory toxicology, drug discovery and development, cell biology, and predictive safety science.

Main Duties and Responsibilities

* Be responsible to design and deliver nonclinical safety strategies and provide insight and judgement to enable successful development of projects in the RIA portfolio as part of multi-disciplinary teams
* Operate across international boundaries within CPSS and across R&D functions in AstraZeneca to lead and manage projects and stakeholders
* Author high-level regulatory documents (e.g. INDs and IMPDs) and contribute to regulatory interactions with health authorities
* Provide specialist nonclinical expertise for evaluation of in-licensing and out-licensing opportunities
* Contribute to the delivery of the RIA Safety department strategy and objectives

Requirements

* A PhD, or university degree with extensive relevant experience, in Toxicology or equivalent life-science subject is required.
* Experience working within a pharmaceutical project environment, preferably with a primary focus on toxicology science and with knowledge and experience of drug development
* Experience in providing expert design and interpretation of toxicology programs
* Clear project leadership skills required to lead and manage the safety assessment contribution to a portfolio of projects, ability to operate with sensitivity and flexibility within an ever-evolving organisational matrix of project and line management, both functionally and across the business
* Significant skills of influencing and persuasion
* Eagerness for scientific excellence, investigation of mechanisms of toxicity and translation of insights to risk assessment
* Willingness to challenge conventional thinking and implement creative ideas balanced with a high regard and understanding for the regulatory framework in which AstraZeneca operates is expected
* Experience with inhalation toxicology and/or respiratory diseases is an advantage
* A social personality with strong inter-personal skills that contributes to our team culture in which trust, cooperative support, diversity and inclusion enable engaged and motivated colleagues to deliver and develop.

We would like to know more about you. If you are interested, apply now!

For more information please contact Jorrit Hornberg, Head of RIA Safety, jorrit.hornberg(at)astrazeneca.com

Welcome with your application no later than October 31, 2019.

Additional information

Preferred location is AstraZeneca's dynamic R&D site in Gothenburg, Sweden but for the right candidate Cambridge, UK is also an option.

Our Gothenburg site: https://www.astrazeneca.com/our-science/gothenburg.html

Culture and atmosphere of the Gothenburg site: https://www.linkedin.com/feed/update/urn:li:activity:6496327311678410752/

Life in Gothenburg and Sweden: https://www.movetogothenburg.com/

AZRespi #GMD

Varaktighet, arbetstid
Heltid Permanent

Publiceringsdatum
2019-10-03

Ersättning
Not Specified

Så ansöker du
Sista dag att ansöka är 2019-10-31
Klicka på denna länk för att göra din ansökan

Företag
Astrazeneca AB

Arbetsgivarens referens
Arbetsgivarens referens för detta jobb är "R-062642".

Omfattning
Detta är ett heltidsjobb.

Arbetsgivare
Astrazeneca AB (org.nr 556011-7482)

Arbetsplats
AstraZeneca

Jobbnummer
4880999

Observera att sista ansökningsdag har passerat.

Prenumerera på jobb från AstraZeneca AB

Fyll i din e-postadress för att få e-postnotifiering när det dyker upp fler lediga jobb hos AstraZeneca AB: